Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | +0.24% | -36.75% | -17.36% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 75.86M | Sales 2025 * | 89.25M | Capitalization | 245M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -29M | EV / Sales 2024 * | 3.52 x |
Net Debt 2024 * | 22.63M | Net Debt 2025 * | 43.9M | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 * |
-7.32
x | P/E ratio 2025 * |
-8.51
x | Employees | 171 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.19% |
Latest transcript on NeuroPace, Inc.
1 day | +0.24% | ||
1 week | -36.75% | ||
Current month | -34.41% | ||
1 month | -36.89% | ||
3 months | -44.42% | ||
6 months | +0.35% | ||
Current year | -17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rebecca Kuhn
FOU | Founder | 63 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Andrade
BRD | Director/Board Member | 52 | 21-10-31 |
Joseph Lacob
BRD | Director/Board Member | 68 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 8.52 | +0.24% | 250,455 |
24-05-10 | 8.5 | +6.65% | 336,451 |
24-05-09 | 7.97 | -36.75% | 452,601 |
24-05-08 | 12.6 | -5.26% | 76,064 |
24-05-07 | 13.3 | -1.26% | 51,351 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.36% | 245M | |
+11.29% | 225B | |
+8.76% | 186B | |
+12.90% | 135B | |
+25.95% | 107B | |
+0.34% | 63.56B | |
+11.08% | 51.04B | |
+5.62% | 51.32B | |
+6.28% | 43.3B | |
+4.80% | 36.99B |
- Stock Market
- Equities
- NPCE Stock